|
Results for ATTORNEY: nixon peabody llp
Showing 1 - 10 of 4941
The present invention relates to substantially pure piperidine derivative compounds of the formulae: ##STR1## wherein R.sub.1 is hydrogen or hydroxy; R.sub.2 is hydrogen; or R.sub.1 and R.sub.2 taken together form a second bond between the carbon atoms bearing R.sub.1 and R.sub.2 ; R.sub.3 is --COOH or --COOR.sub.4 ; R.sub.4 has 1 to 6 carbon atoms; A, B, and D are the substituents of their respective rings each of which may be different or the same and are hydrogen, halogens, alkyl, hydroxy, al...
A flexible infrared emissive module comprises an electrically insulating carrier layer (12), an electrically conductive layer (14) mounted to the carrier layer, an electrically insulating top layer (18) mounted to the carrier and electrically conductive layers on one side of the carrier layer and an electrically insulating bottom layer (16) mounted to the other side of the carrier layer. The carrier layer comprises a vinyl film, and the top and bottom layers comprise a polyester film, which are ...
The present invention is directed to a method of producing a cereal plant cell or protoplast useful for regeneration of a water stress or salt stress tolerant cereal plant by transforming the cereal plant cell or protoplast with a nucleic acid encoding a late embryogenesis abundant protein. A transgenic cereal plant or cereal plant cell or protoplast transformed with a nucleic acid encoding a late embryogenesis abundant protein is also provided. An LEA protein gene, HVA1, from barley (Hordeum vu...
An electronic product, such as a personal computer or electronic organizer with an open-surfaced receptacle or slot is described. An electronic product incorporating such a receptacle is able to accommodate an insertable electronic module, such as a PCMCIA card, that is thicker than could be incorporated in the receptacle if a portion of the inserted module were not permitted to protrude through the receptacle along the open surface. One embodiment of the invention includes a display, a platform...
The present invention relates to a method of treating a patient with a fibrotic or fibroproliferative disorder and a method of suppressing formation of collagen and collagen-like substances or biosynthesis of procollagen in living systems by administering to a patient or living system, respectively, an effective amount of a compound of Formulae (I) or (II) and derivatives thereof: ##STR1## R.sub.1, R.sub.2, R.sub.3, and R.sub.4 each individually represent a hydrogen, an alkyl, alkenyl, or alkoxy...
An expandable keyboard in accordance with the present invention provides a full-size or expanded keyboard for typing which folds to minimize size during transport or storage, and can be converted to substantially twice its folded length for use. Its use of sliding segments permits a straight hinge line for folding. Its operating mechanism supports a large number of electrical interconnections between the hinged wing section or sections and the central platform, and provides for straight-line eng...
The present invention is directed to a non-human mammal with at least 30% of all of its glial cells in its corpus callosum being human glial cells and/or at least 5% of all of its glial cells in the white matter of its brain and/or brain stem being human glial cells. Methods of producing and using the non-human mammal are also disclosed.
The invention provides mutants of IL-18 with lower affinity to IL-18BP than the wild type IL-18 molecule.
A gaming machine comprises a primary gaming display for presenting the outcome of a wagering or bonus game and a video display. In response to a wager, an outcome is generated and displayed in a display area. The video display provides a video image superimposed upon primary game display. The video image may be interactive with the primary game display and include such graphics as payout values, a pay table, pay lines, bonus game features, special effects, thematic scenery, and instructional inf...
Lipid phosphate phosphatase proteins, genes coding for them, vectors and cells comprising them, antibodies directed against them, methods of identifying compounds binding to them and functional interactors as well as to the use of proteins, genes, vectors, cells, interacting compounds and functional interactors for treating neuronal diseases and/or injuries.
|
|